News - Vaccines, Valneva

Filter

Current filters:

VaccinesValneva

Popular Filters

Valneva initiates fourth antibody discovery program for Sanofi Pasteur

25-02-2014

European biotechnology company Valneva has initiated a fourth monoclonal antibody discovery program for…

Antibiotics and Infectious diseasesBiotechnologyLicensingResearchSanofiSanofi PasteurVaccinesValneva

Valneva licenses EB66 to IAVI for preventive HIV vaccine

02-10-2013

Biotech firm Valneva says that it has licensed the use of its EB66 cell line to the International AIDS…

Anti-viralsBiotechnologyLicensingVaccinesValneva

Biological E's Japanese Encephalitis vaccine prequalified by WHO

23-07-2013

Indian biopharmaceutical company Biological E (BioE) and European biotech company Valneva (Euronext:…

Biological E LtdBiotechnologyProductionRegulationVaccinesValneva

Merger between Intercell and Vivalis planned to complete soon

14-05-2013

French biotech firm Vivalis (Euronext: VLS) previously-announced acquisition of Intercell (ICEL.VI) in…

BiotechnologyIntercellMergers & AcquisitionsVaccinesValnevaVivalis

Vivalis and Intercell announce "merger of equals"

18-12-2012

French biotech firm Vivalis (Euronext: VLS) has entered into an accord to acquire Intercell (ICEL.VI)…

BiotechnologyIntercellMergers & AcquisitionsVaccinesValnevaVivalis

Back to top